Questions About Cancer? 1-800-4-CANCER

Cancer Drug Information

  • Posted: 08/28/2009
  • Updated: 11/04/2011

Toremifene

listen 1  (TOR-eh-mih-FEEN)

This page contains brief information about toremifene and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Fareston
FDA Approved: Yes

Use in Cancer

Toremifene is approved to treat:

More About Toremifene

Definition from the NCI Drug Dictionary 2 - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Toremifene 3 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Targeted Cancer Therapies 4 - Information about the use of this drug to treat cancer.

Clinical Trials Accepting Patients

Find Clinical Trials for Toremifene 5 - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top



Glossary Terms

breast cancer (brest KAN-ser)
Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.
cancer (KAN-ser)
A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.
estrogen receptor negative (ES-truh-jin reh-SEP-ter NEH-guh-tiv)
Describes cells that do not have a protein to which the hormone estrogen will bind. Cancer cells that are estrogen receptor negative do not need estrogen to grow, and usually do not stop growing when treated with hormones that block estrogen from binding. Also called ER-.
estrogen receptor positive (ES-truh-jin reh-SEP-ter PAH-zih-tiv)
Describes cells that have a receptor protein that binds the hormone estrogen. Cancer cells that are estrogen receptor positive may need estrogen to grow, and may stop growing or die when treated with substances that block the binding and actions of estrogen. Also called ER+.
metastasize (meh-TAS-tuh-size)
To spread from one part of the body to another. When cancer cells metastasize and form secondary tumors, the cells in the metastatic tumor are like those in the original (primary) tumor.
postmenopausal (post-MEH-nuh-PAW-zul)
Having to do with the time after menopause. Menopause (“change of life”) is the time in a woman's life when menstrual periods stop permanently.

Table of Links

1http://www.cancer.gov/PublishedContent/Media/CDR/Media/730894.mp3
2http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=41103
3http://www.nlm.nih.gov/medlineplus/druginfo/meds/a608003.html
4http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted
5http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41103&idtype=1
6http://www.cancer.gov/cancertopics/druginfo/alphalist
7http://www.cancer.gov/cancertopics/druginfo/drug-page-index
8http://www.cancer.gov/clinicaltrials/learningabout/approval-process-for-cancer-
drugs
9http://www.cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access